Current Fiscal Year Data

In 1984 a group of distinguished trustees appointed by the Delaware Court of Chancery assumed responsibility for the Institute and reaffirmed its primary purpose of basic medical research. They guided the Institute through the sale of the Hughes Aircraft Company on December 20, 1985, creating the endowment that is its principal source of funding. This reorganization and sale of Hughes Aircraft marks the beginning of the modern era of Institute activities, and serves as the starting point for the presentation of cumulative expenditure information.

At the end of fiscal year 2012, the Institute had $16.1 billion in diversified net assets, making it the nation's largest private supporter of academic biomedical research.

		Download the 2012 Audited Financial Statements (PDF)

Questions or comments about information contained in the Institute's audited financial statements should be directed to Nitin Kotak, Vice President and Chief Financial Officer or to Monique Marcus, Assistant Controller.

	10 Year Snapshot 2003-2012 $7.0 billion Direct support for research and science education $6.1 billion Cumulative expenditures for scientific research 79 % Proportion of expenditures for scientific research $751 million Investment in laboratory and other space $907 million Cumulative expenditures for Grants 10.6 % Average annual rate of return on endowment		Today FY 2012 $16.1 billion Value of endowment at the end of the year $919 million Disbursements for scientific research, grants, and capital initiatives $800 million Disbursements for scientific research and capital initiatives $119 million Disbursements for science education including international